Methylphenidate Hydrochloride Extended-Release 50 mg/1 (Methylphenidate Hydrochloride CAPSULE, EXTENDED RELEASE) 50 mg/1

Methylphenidate Hydrochloride Extended-Release 50 mg/1 capsules are designed for sustained release, offering a long-lasting effect. This medication is commonly used to manage certain conditions related to focus and attention.

Strength

50 mg/1

Pack Size

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0406-1850-01)

Manufacturer / TM Owner

SpecGx LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methylphenidate Hydrochloride Extended-Release 50 mg/1 capsules are typically used to help improve focus and reduce impulsivity. This medication is often prescribed for conditions that affect attention and impulse control, providing extended relief throughout the day.

Side Effects

Common effects of Methylphenidate Hydrochloride Extended-Release 50 mg/1 capsules may include increased alertness and concentration. Some users may experience changes in appetite or sleep patterns while taking this medication.

Precautions & Warnings

It is important to handle Methylphenidate Hydrochloride Extended-Release 50 mg/1 capsules with care. Always follow the guidance of a healthcare professional regarding usage and storage. Avoid sharing this medication with others.

Avoid Interactions

Methylphenidate Hydrochloride Extended-Release 50 mg/1 capsules may interact with certain substances, including alcohol and other medications that affect the central nervous system. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Methylphenidate Hydrochloride Extended-Release 50 mg/1 capsules are used to help improve focus and reduce impulsivity in conditions that affect attention and impulse control.

Methylphenidate Hydrochloride Extended-Release 50 mg/1 capsules are designed for oral administration. Follow the instructions provided by your healthcare professional.

Common effects may include increased alertness and concentration, as well as changes in appetite or sleep patterns.

Methylphenidate Hydrochloride Extended-Release 50 mg/1 capsules may interact with other medications. Consult your healthcare provider before combining with other treatments.

Always follow the guidance of a healthcare professional regarding usage and storage. Avoid sharing this medication with others.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.